HYDRIDE-L
|
|
- CAS-Nr.
- 41639-74-1
- Englisch Name:
- HYDRIDE-L
- Synonyma:
- HYDRIDE-L;Bimaprost;Latanprost;Lactondiol B;Lactonediol B;BP-2 (LT-EDI);Bimatoprost Impurity 19;BP-2 (LT-EDI)(Bimaprost、Latanprost);(3aR,4R,5R,6aS)-5-hydroxy-4-((S,E)-3-hydroxy-5-phenylpent-1-enyl)hexahydro-2H-cyclopenta[b]furan-2-one;(3aR,4R,5R,6aS)-5-Hydroxy-4-((S,E)-3-hydroxy-5-phenylpent-1-en-1-yl)hexahydro-2H-cyclopenta[b]furan-2-one
- CBNumber:
- CB92455397
- Summenformel:
- C18H22O4
- Molgewicht:
- 302.36
- MOL-Datei:
- 41639-74-1.mol
|
HYDRIDE-L Eigenschaften
- Siedepunkt:
- 509.2±50.0 °C(Predicted)
- Dichte
- 1.286±0.06 g/cm3(Predicted)
- storage temp.
- 2-8°C
- pka
- 14.16±0.20(Predicted)
Sicherheit
- Risiko- und Sicherheitserkl?rung
- Gefahreninformationscode (GHS)
Bildanzeige (GHS) |
|
Alarmwort |
Warnung |
Gefahrenhinweise |
Code |
Gefahrenhinweise |
Gefahrenklasse |
Abteilung |
Alarmwort |
Symbol |
P-Code |
H315 |
Verursacht Hautreizungen. |
Hautreizung |
Kategorie 2 |
Warnung |
src="/GHS07.jpg" width="20" height="20" /> |
P264, P280, P302+P352, P321,P332+P313, P362 |
|
Sicherheit |
P280 |
Schutzhandschuhe/Schutzkleidung/Augenschutz tragen. |
|
HYDRIDE-L Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
PGX 9 is a useful intermediate in the chemoenzymatic synthesis of Latanoprost and Bimatoprost, that are prostaglandin analogs widely used for glaucoma treatment.
HYDRIDE-L Upstream-Materialien And Downstream Produkte
Upstream-Materialien
2H-Cyclopenta[b]furan-2-one, 5-(benzoyloxy)hexahydro-4-[(1E,3S)-3-hydroxy-5-phenyl-1-pentenyl]-, (3aR,4R,5R,6aS)-
[1,1'-Biphenyl]-4-carboxylic acid, (3aR,4R,5R,6aS)-hexahydro-4-[(1E,3S)-3-hydroxy-5-phenyl-1-pentenyl] -2-oxo-2H-cyclopenta[b]furan-5-yl ester
Dimethyl (2-oxo-4-phenylbutyl)phosphonate
Downstream Produkte
HYDRIDE-L Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 67)Lieferanten
- HYDRIDE-L
- (+)-(3aR,4R,5r,6aS)-Hexahydro-5-hydroxy-4-[(1E,3R)-3-hydroxy-5-phenyl-1-pentenyl]-2H-cyclopenta[b]furan-2-one
- BP-2 (LT-EDI)
- BP-2 (LT-EDI)(Bimaprost、Latanprost)
- (3aR,4R,5R,6aS)-5-Hydroxy-4-((S,E)-3-hydroxy-5-phenylpent-1-en-1-yl)hexahydro-2H-cyclopenta[b]furan-2-one
- 2H-Cyclopenta[b]furan-2-one,hexahydro-5-hydroxy-4-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]-,(3aR,4R,5R,6aS)-
- (3aR,4R,5R,6aS)-Hexahydro-5-hydroxy-4-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]-2H-cyclopenta[b]furan-2-one
- Lactondiol B
- Bimaprost
- Latanprost
- (3aR,4R,5R,6aS)-hexahydro-5-hydroxy-4-[(1E,3S)-5-phenyl-3-hydroxy-(1E)-pentenyl]-2H-cyclopentane [β] furan-2-one
- (3aR,4R,5R,6aS)-Hexahydro-5-hydroxy-4-[(1E,3S)-3-hydroxy-5-phenyl-1-pentenyl]-2H-cyclopenta[b]furan-2-one
- Lactonediol B
- Bimatoprost Impurity 19
- (3aR,4R,5R,6aS)-5-hydroxy-4-[(3S)-3-hydroxy-5-phenylpent-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-one
- (+)-(3Ar,4R,5R,6as)-hexahydro-5-hydroxy-4-[(1E,3R)-3-hydroxy-5-phenyl-1-pentenyl]-2H-cyclopenta[b]furan-2-one
- (3aR,4R,5R,6aS)-5-hydroxy-4-((S,E)-3-hydroxy-5-phenylpent-1-enyl)hexahydro-2H-cyclopenta[b]furan-2-one
- 41639-74-1